SS
Shagun Singh RBC Capital Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Intuitive Surgical
ISRG
$167B
| $466.95 | $615 |
32%
upside
| Outperform | 17 days ago |
|
2 |
2
Zimmer Biomet
ZBH
$20.9B
| $105.69 | $115 |
9%
upside
| Outperform | 28 days ago |
|
3 |
3
Insulet
PODD
$24.5B
| $348.45 | $350 |
0%
upside
| Outperform | 28 days ago |
|
4 |
4
Tandem Diabetes Care
TNDM
$851M
| $12.59 | $25 |
99%
upside
| Outperform | 29 days ago |
|
5 |
5
Inspire Medical Systems
INSP
$2.56B
| $86.42 | $180 |
108%
upside
| Outperform | 1 month ago |
|
6 |
6
Teleflex
TFX
$5.78B
| $130.72 | $135 |
3%
upside
| Sector Perform | 1 month ago |
|
7 |
7
Penumbra
PEN
$11B
| $281.42 | $325 |
15%
upside
| Outperform | 1 month ago |
|
8 |
8
Edwards Lifesciences
EW
$47.5B
| $80.91 | $89 |
10%
upside
| Outperform | 1 month ago |
|
9 |
9
Johnson & Johnson
JNJ
$430B
| $178.38 | $185 |
4%
upside
| Outperform | 1 month ago |
|
10 |
10
Abbott
ABT
$231B
| $132.94 | $147 |
11%
upside
| Outperform | 1 month ago |
|
11 |
11
Medtronic
MDT
$119B
| $92.90 | $101 |
9%
upside
| Outperform | 3 months ago |
|
12 |
12
Boston Scientific
BSX
$159B
| $107.21 | $120 |
12%
upside
| Outperform | 4 months ago |
|
13 |
13
Stryker
SYK
$150B
| $392.27 | $435 |
11%
upside
| Outperform | 7 months ago |
|
14 |
14
Globus Medical
GMED
$8.19B
| $60.61 | $92 |
52%
upside
| Outperform | 10 months ago |
|
15 |
15
DexCom
DXCM
$31.6B
| $80.54 | $115 |
43%
upside
| Outperform | 10 months ago |
|